QQ客服 官方微博 反馈留言

	Wogonin mitigates nonalcoholic fatty liver disease via enhancing PPAR alpha/AdipoR2, in vivo and in vitro
	Chen, Jing; Liu, Jie; Wang, Ye; Hu, Xuemei; Zhou, Feng; Hu, Yimeng; Yuan, Yin; Xu, Yancheng
刊名	BIOMEDICINE & PHARMACOTHERAPY
	2017
卷号	91
关键词	Wogonin NAFLD Oxidative stress PPAR alpha AdipoR2
ISSN号	0753-3322
DOI	10.1016/j.biopha.2017.04.125
URL标识	查看原文
收录类别	SCIE
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4091367
专题	武汉大学
推荐引用方式 GB/T 7714	Chen, Jing,Liu, Jie,Wang, Ye,et al. Wogonin mitigates nonalcoholic fatty liver disease via enhancing PPAR alpha/AdipoR2, in vivo and in vitro[J]. BIOMEDICINE & PHARMACOTHERAPY,2017,91.
APA	Chen, Jing.,Liu, Jie.,Wang, Ye.,Hu, Xuemei.,Zhou, Feng.,...&Xu, Yancheng.(2017).Wogonin mitigates nonalcoholic fatty liver disease via enhancing PPAR alpha/AdipoR2, in vivo and in vitro.BIOMEDICINE & PHARMACOTHERAPY,91.
MLA	Chen, Jing,et al."Wogonin mitigates nonalcoholic fatty liver disease via enhancing PPAR alpha/AdipoR2, in vivo and in vitro".BIOMEDICINE & PHARMACOTHERAPY 91(2017).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。